---
title: "entacapone - Parkinson's disease"
sidebar: mydoc_sidebar
permalink: entacaponeparkinsonsdisease.html
toc: false 
---

{% include image.html file="entacaponeparkinsonsdisease.png" alt="entacaponeparkinsonsdisease" %}![Path Visualization](/images/entacaponeparkinsonsdisease.png)

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C071192 | entacapone | Drug |
| UniProt:P21964 | Catechol O-methyltransferase | Protein |
| GO:0102084 | L-dopa O-methyltransferase activity | MolecularActivity |
| CHEBI:15765 | L-dopa | ChemicalSubstance |
| GO:0001963 | synaptic transmission, dopaminergic | BiologicalProcess |
| MESH:D010300 | Parkinson's disease | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Entacapone | NEGATIVELY REGULATES | Catechol O-Methyltransferase |
| Catechol O-Methyltransferase | POSITIVELY REGULATES | L-Dopa O-Methyltransferase Activity |
| L-Dopa O-Methyltransferase Activity | DECREASES ABUNDANCE OF | L-Dopa |
| L-Dopa | POSITIVELY CORRELATED WITH | Synaptic Transmission, Dopaminergic |
| Synaptic Transmission, Dopaminergic | NEGATIVELY CORRELATED WITH | Parkinson'S Disease |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB:DB00494#mechanism-of-action](https://go.drugbank.com/drugs/DB:DB00494#mechanism-of-action){:target="_blank"}